GxP compliance is a collection of quality guidelines that ensures products are safe, data is accurate, and processes are properly controlled in regulated industries such as pharmaceuticals, biotech, and medical devices. For any company working with medicines, laboratory testing, or medical equipment GxP compliance is not optional. It is legally required.
Table of Contents
- What is GxP Compliance?
- Why GxP Compliance Matters in Life Sciences
- The Main Types of GxP: GMP, GLP, GCP, and GDP
- The GxP Compliance Lifecycle Step by Step
- What is Validation in GxP? (IQ, OQ, PQ Explained)
- GxP Documentation Requirements
- 21 CFR Part 11 and Electronic Records
- Common GxP Compliance Challenges
- How Software Simplifies GxP Compliance
- How to Prepare for a GxP Audit
- GxP Best Practices for 2025
- Frequently Asked Questions
What is GxP Compliance?
GxP compliance refers to a set of regulations and quality guidelines used across regulated industries to ensure that products are consistently produced, tested, and documented to the highest standards of safety and reliability.
The “G” stands for Good, the “x” is a placeholder for the specific practice area (Manufacturing, Laboratory, Clinical, etc.), and the “P” stands for Practice.
In plain terms: GxP tells regulated companies exactly how to work how to manufacture, test, document, and manage data so that every product that reaches patients or consumers is safe and effective.
GxP applies to any company that:
- Manufactures pharmaceutical products or medical devices
- Conducts laboratory testing or clinical trials
- Stores or distributes regulated medicines
- Uses electronic systems to manage regulated records
If your company falls into any of these categories and is subject to oversight from the FDA (United States), EMA (European Union), or equivalent global health authorities, GxP compliance is a legal obligation not a choice.
Why GxP Compliance Matters in Life Sciences
GxP compliance is the backbone of quality and patient safety across the life sciences industry. Without it, companies face serious operational, legal, and reputational risks.
The risks of non-compliance include:
- Product recalls defective or unsafe products reaching the market
- Warning letters and regulatory penalties from the FDA or EMA
- Data integrity failures records that cannot be trusted or verified
- Patient safety incidents the most severe consequence of poor manufacturing controls
- Business disruption import bans, facility shutdowns, or loss of operating license
The benefits of strong GxP compliance:
- Products are consistently safe and effective
- Data is accurate, traceable, and audit-ready
- Regulatory inspections are manageable and predictable
- Client and regulator trust is maintained
- Operational risk is significantly reduced
For growing companies entering Phase 3 clinical trials or commercial manufacturing, getting GxP compliance right from the start is critical. The cost of fixing non-compliance after an FDA inspection is always far greater than building it correctly from day one.
The Main Types of GxP: GMP, GLP, GCP, and GDP
GxP is not a single regulation it is an umbrella term covering several distinct practice areas. Each one applies to a different part of the product lifecycle.
1. GMP Good Manufacturing Practice
What is GMP? GMP is the set of regulations that governs how pharmaceutical products, medical devices, and nutraceuticals are manufactured. It ensures that every batch of a product is produced under controlled, documented, and validated conditions.
GMP focuses on:
- Equipment validation and maintenance
- Manufacturing process control
- Environmental and facility standards
- Quality assurance and quality control
- Batch record documentation
For pharmaceutical and biotech companies, GMP compliance is enforced by the FDA under 21 CFR Parts 210 and 211, and by the EMA under EU GMP guidelines.
Managing GMP equipment records, maintenance schedules, and calibration activities is significantly easier with a purpose-built validated CMMS software designed specifically for FDA and EMA-regulated environments.
2. GLP Good Laboratory Practice
What is GLP? GLP governs how non-clinical laboratory studies are planned, performed, monitored, recorded, and reported. It ensures that laboratory data submitted to regulators is reliable, reproducible, and scientifically sound.
GLP covers:
- Test method validation and verification
- Laboratory equipment calibration
- Accurate and complete data recording
- Standard operating procedures (SOPs) for lab processes
- Personnel training and competency documentation
Laboratory equipment calibration is one of the most critical GLP requirements. Using dedicated GxP calibration software allows lab teams to track calibration schedules, store certificates, and maintain tamper-evident calibration records all in one secure system.
3. GCP Good Clinical Practice
What is GCP? GCP is an international quality standard for the design, conduct, recording, and reporting of clinical trials involving human subjects. It ensures that the rights, safety, and wellbeing of trial participants are protected and that clinical trial data is credible.
GCP focuses on:
- Informed consent and patient safety protocols
- Clinical trial design and protocols
- Data transparency and integrity
- Ethical review and regulatory reporting
- Adverse event documentation
4. GDP Good Documentation Practice
What is GDP? GDP is arguably the most cross-cutting GxP requirement. It defines how all regulated records should be created, managed, stored, and retrieved regardless of whether those records relate to manufacturing, lab testing, or clinical activities.
The core principles of good documentation are often remembered with the acronym ALCOA+:
| Principle | Meaning |
| A Attributable | Records must identify who created them and when |
| L Legible | Records must be readable and permanent |
| C Contemporaneous | Records must be created at the time of the activity |
| O Original | First capture of data must be preserved |
| A Accurate | Records must reflect what actually happened |
| + | Complete, Consistent, Enduring, Available |
The GxP Compliance Lifecycle Step by Step
GxP compliance is not a project with a start and end date it is a continuous lifecycle that runs for as long as your company operates in a regulated environment.
Phase 1: Planning
- Define the regulatory requirements that apply to your company (FDA, EMA, ICH)
- Identify which systems, processes, and records fall under GxP scope
- Conduct a risk assessment to prioritize compliance activities
Phase 2: Implementation
- Design and document compliant processes and SOPs
- Configure and set up software systems appropriate for regulated use
- Define roles, responsibilities, and access controls
Phase 3: Validation
- Qualify equipment and software systems (IQ, OQ, PQ see next section)
- Execute validation protocols and document results
- Resolve deficiencies before systems go live
Phase 4: Operation
- Use validated systems for daily GxP activities
- Track calibration schedules, maintenance events, and validation statuses
- Monitor data integrity on an ongoing basis
Phase 5: Audit and Review
- Conduct internal audits against written procedures
- Respond to regulatory inspections with complete, organized records
- Review findings and implement corrective actions
Phase 6: Continuous Improvement
- Update SOPs and validation documentation when processes change
- Re-qualify systems after significant changes
- Stay current with evolving regulatory guidance
Using purpose-built validation tracking software helps companies manage this entire lifecycle tracking qualification status, upcoming reviews, and documentation completeness across all regulated systems.
What is Validation in GxP? (IQ, OQ, PQ Explained Simply)
Validation is the documented process of proving that a system, process, or piece of equipment consistently performs the way it is supposed to within defined, acceptable limits.
In GxP, validation is not optional. The FDA and EMA expect companies to demonstrate that the systems they rely on for regulated activities have been formally qualified before use.
The Three Core Stages of Validation:
IQ Installation Qualification “Is it installed correctly?” IQ confirms that equipment or software has been delivered, installed, and configured according to specifications. This includes verifying hardware, software versions, operating environment, and setup documentation.
OQ Operational Qualification “Does it work as intended?” OQ tests that the system operates correctly across its intended operating range. For software, this means testing core workflows, access controls, audit trail functionality, and system behavior under normal and edge-case conditions.
PQ Performance Qualification “Does it perform reliably under real conditions?” PQ verifies that the system performs consistently during actual use under realistic workloads, with real users, and in the actual operating environment.
Why validation matters for audits:
During an FDA or EMA inspection, inspectors will ask to see your validation documentation. If you cannot produce complete IQ/OQ/PQ records, your system may be considered unvalidated even if it is technically functioning correctly. The documentation is the compliance evidence.
GxP Documentation Requirements
Documentation is the single most important element of GxP compliance. Regulators cannot audit a process they cannot read about. If it was not documented, it did not happen.
The core documents every GxP-regulated company must maintain:
Standard Operating Procedures (SOPs) Written, approved instructions that describe how regulated activities must be carried out. SOPs must be version-controlled, reviewed regularly, and accessible to relevant personnel.
Validation Documents IQ, OQ, and PQ protocols and reports for all regulated equipment and software systems. These must be approved before execution and filed permanently.
Calibration Records Complete history of calibration activities for each piece of measuring equipment, including the calibration standard used, results, pass/fail status, and the identity of the person performing the calibration.
Audit Logs / Audit Trails A chronological, tamper-evident record of who accessed, created, or modified a regulated record and when. Audit trails are a core 21 CFR Part 11 requirement for electronic records systems.
Training Records Documentation that each employee has read, understood, and been trained on the SOPs relevant to their role.
Change Control Records Documentation of any change to a validated process, system, or method including the reason for the change, impact assessment, and re-validation activities required.
21 CFR Part 11 and Electronic Records
What is 21 CFR Part 11? 21 CFR Part 11 is the FDA regulation that governs the use of electronic records and electronic signatures in FDA-regulated environments. It defines the requirements that electronic systems must meet to be considered equivalent to paper records in terms of trustworthiness and reliability.
If your company uses software to create, store, modify, or retrieve GxP records that software must support 21 CFR Part 11 requirements.
Core 21 CFR Part 11 requirements:
- Audit trails all record creation, modification, and deletion must be logged with a date/time stamp and user identity
- Access controls role-based permissions must prevent unauthorized access or modification of records
- System validation the software itself must be validated for its intended use
- Record retention electronic records must be secure, backed up, and retrievable throughout their required retention period
- Electronic signatures when used, electronic signatures must be uniquely linked to one individual and cannot be reused by another person
For companies operating under EU GMP, the equivalent standard is EMA Annex 11, which covers computerised systems in the same way that Part 11 covers electronic records.
Using a system that is purpose-built for regulated environments rather than adapting a generic tool dramatically reduces the complexity of achieving and demonstrating 21 CFR Part 11 compliance. Learn how GxPReady’s maintenance and calibration management platform is designed to support these requirements from day one.
Common GxP Compliance Challenges
Even well-intentioned regulated companies run into the same recurring compliance problems. Understanding these challenges in advance helps you avoid them.
1. Managing records in spreadsheets
Spreadsheets are not validated systems. They have no audit trail, no access controls, and no automated reminders. Using them for GxP records is a significant compliance risk and a common FDA inspection finding.
2. Delayed or incomplete system validation
Many companies begin using software systems before validation is complete. This creates an uncomfortable situation during inspections: the system is in use, but there is no documented evidence that it was qualified.
3. Poor audit readiness
Being able to retrieve a specific record in minutes during an inspection is not just convenient it is expected. Companies that rely on manual file searches or disconnected systems often struggle to respond quickly to inspector requests.
4. Inadequate change control
When a validated process or system changes without proper change control documentation, the original validation may no longer be considered valid. This is one of the most common triggers for FDA warning letters.
5. Training record gaps
Regulators routinely check whether the people performing GxP activities have been trained on the relevant SOPs. Missing or outdated training records are an easy finding for experienced inspectors.
How Software Simplifies GxP Compliance
Modern compliance software does not just store records it actively helps your team stay compliant by automating key tasks, reducing human error, and making inspection readiness the default state rather than a scramble.
What purpose-built GxP software delivers:
Automated scheduling and reminders Calibration due dates, preventive maintenance intervals, and revalidation deadlines are tracked automatically. Teams receive reminders before items fall overdue not after.
Tamper-evident audit trails Every record creation, modification, or access event is logged automatically with a date/time stamp and user identity. This satisfies 21 CFR Part 11 audit trail requirements without any manual effort.
Role-based access control Permissions are configured by role, so only authorized users can create, approve, or modify specific record types. This protects record integrity and supports compliance with access control requirements.
Instant record retrieval During an inspection, being able to pull up a calibration certificate or maintenance history in seconds rather than searching through filing cabinets demonstrates operational control and inspires regulator confidence.
Included validation documentation The best platforms for regulated companies include IQ and OQ documentation at deployment, so qualification can be completed quickly without waiting on external deliverables.
GxPReady’s maintenance management software and integrated calibration and validation modules are designed specifically for this purpose giving growing regulated teams inspection-ready records from the first day of use.
How to Prepare for a GxP Audit
Whether you are preparing for a scheduled FDA inspection, an EMA audit, or an internal compliance review, the approach is the same: structured preparation, organized documentation, and a confident team.
Step-by-step audit preparation checklist:
Step 1 Review your documentation landscape Confirm that all SOPs are current, version-controlled, and approved. Identify any that have expired or are due for review.
Step 2 Verify validation status Check that all regulated equipment and software systems have complete, approved IQ/OQ/PQ documentation. Any gaps must be addressed before the inspection.
Step 3 Audit your audit trails Review the audit trails in your electronic systems. Confirm that they are complete, tamper-evident, and retrievable. Unexplained gaps in audit trail records are a red flag for inspectors.
Step 4 Check calibration and maintenance records Ensure all calibration certificates are filed, that no equipment is overdue for calibration, and that all preventive maintenance events have been documented.
Step 5 Verify training records Confirm that every employee with GxP responsibilities has current, signed training records for all relevant SOPs.
Step 6 Conduct a mock inspection Have an internal team member or external consultant perform a mock walk-through of the facility and systems, asking the same questions an FDA or EMA inspector would ask.
GxP Best Practices for 2026
Regulatory expectations continue to evolve. Here are the practices that matter most for companies trying to stay ahead of compliance requirements in 2025 and beyond.
Use validated systems not adapted ones. General-purpose tools like spreadsheets, shared drives, or generic project management software introduce compliance risk. Systems designed and validated for regulated use eliminate that risk from the start.
Implement electronic records early. Transitioning from paper to electronic records is significantly easier before you scale. Waiting until commercialization makes the change far more disruptive and expensive.
Keep validation documentation current. Every significant change to a validated system, process, or method requires a change control review and potentially a re-validation activity. Build this into your standard operating rhythm, not as a catch-up exercise.
Make audit readiness the default not a sprint before an inspection. Companies that maintain inspection-ready records every day spend far less time and money on audit preparation than those who scramble when an inspection is announced.
Choose software that scales with you. A system that works well at 15 employees should still work well at 150. Look for platforms that offer predictable pricing, no long-term lock-in, and support for growing teams. Explore the full capabilities of the GxPReady platform to see how it supports growing regulated companies from Phase 3 through full commercialization.
Frequently Asked Questions
What is GxP compliance in simple terms?
GxP compliance means following a set of quality rules that ensure your products are safe, your processes are controlled, and your records are accurate and trustworthy. It is required by regulatory agencies like the FDA and EMA for companies in pharmaceuticals, biotech, and medical devices.
What does GxP stand for?
GxP stands for “Good x Practice,” where “x” is replaced by the specific practice area for example, GMP (Manufacturing), GLP (Laboratory), or GCP (Clinical).
Who needs GxP compliance?
Any company that manufactures pharmaceutical products, conducts regulated laboratory testing, runs clinical trials, or produces medical devices is required to follow GxP guidelines. This includes biotech startups, pharmaceutical manufacturers, contract research organizations (CROs), and nutraceutical companies operating under GMP.
Is GxP compliance mandatory?
Yes. Regulatory authorities including the FDA (US), EMA (EU), MHRA (UK), and equivalent global agencies require GxP compliance as a condition of operating in regulated industries. Non-compliance can result in warning letters, product recalls, import alerts, or facility shutdowns.
What is the difference between GMP and GxP?
GxP is the broad umbrella term that covers all Good Practice guidelines. GMP (Good Manufacturing Practice) is one specific type of GxP that focuses specifically on the manufacturing of products. Other types include GLP (laboratory), GCP (clinical), and GDP (documentation).
What is a validated CMMS and do I need one?
A validated CMMS (Computerized Maintenance Management System) is a maintenance management platform that has been formally qualified for use in a GxP-regulated environment. If your company uses a CMMS to manage equipment maintenance, calibration, or service records that form part of your GxP compliance program, that system should be validated. A purpose-built validated CMMS includes the audit trails, access controls, and validation documentation that regulated companies require.
How long does it take to implement a GxP-compliant system?
It depends heavily on the platform chosen. Enterprise systems can take 3–6 months to deploy and validate. Purpose-built solutions designed for mid-sized regulated companies using a structured approach like Flash Validation™ can typically be configured, qualified, and operational within days.
What is 21 CFR Part 11 and how does it relate to GxP?
21 CFR Part 11 is the FDA regulation that sets requirements for electronic records and electronic signatures in regulated environments. It is directly relevant to any GxP-regulated company that uses software to create or manage GxP records. Compliance with Part 11 requires audit trails, access controls, system validation, and secure record retention.
Conclusion
GxP compliance is the foundation of quality, safety, and regulatory trust in life sciences. It is not a one-time project it is an ongoing commitment to doing things right, every day.
The companies that manage GxP compliance most effectively are those that build compliant systems and processes early, use validated software to automate key tasks, and maintain inspection-ready records as a standard operating practice rather than a reactive scramble.
Whether you are a growing biotech company approaching Phase 3, a pharmaceutical manufacturer preparing for an FDA inspection, or a medical device company transitioning from spreadsheets to a structured compliance system the principles covered in this guide apply directly to your situation.
Key takeaways:
- GxP covers all Good Practice areas: GMP, GLP, GCP, and GDP
- Compliance is a continuous lifecycle not a one-time checklist
- Documentation and audit trails are non-negotiable
- 21 CFR Part 11 applies to any electronic system managing GxP records
- Purpose-built validated software dramatically reduces compliance complexity and audit risk
To see how a validated CMMS purpose-built for FDA and EMA-regulated companies can simplify your calibration, maintenance, and validation tracking explore the full GxPReady product platform.
